HER2-positive breast cancer trials recruiting in Alabama

All HER2-positive breast cancer trials nationally

Cities in Alabama

Recruiting trials in Alabama

• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  NCT01042379 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
  NCT04332588 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · Alabama: Birmingham
• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham